Core Laboratories NV (CLB)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
At a market value of $464M, Core Laboratories NV's free cash flow of $26M (fiscal 2025) would need to grow about 4% a year for the stock to be worth today's price. That is close to what the company has delivered over the last 4 years.
Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Core Laboratories NV's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.
Fundamental grade
Five factors scored 1 to 9 from CLB's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Core Laboratories NV's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $470M | $490M | $510M | $524M | $527M |
| Net income | $20M | $19M | $37M | $31M | $30M |
| Free cash flow | $23M | $15M | $14M | $44M | $26M |
| EPS (diluted) | $0.42 | $0.42 | $0.77 | $0.66 | $0.63 |
| Operating margin | 9.6% | 8.5% | 10.7% | 11.2% | 10.7% |
Where the revenue comes from
Revenue by segments, fiscal 2025. Every breakdown, year by year.
Superinvestors who own CLB
From each investor's latest 13F filing (what a 13F shows). 3 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| John Rogers Ariel Investments |
Added | $164M | 1.6% | Q2 2026 |
| Will Nasgovitz Heartland Advisors |
Added | $12M | 0.55% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | $755,026 | 0.0% | Q2 2026 |
Insider buying
Open-market purchases by Core Laboratories NV's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when CLB trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
What growth does Core Laboratories NV's stock price imply?
At a market value of $464M, Core Laboratories NV would need its free cash flow to grow about 4% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 4 years its free cash flow grew 3% a year.
Are Core Laboratories NV insiders buying the stock?
No open-market insider purchases of CLB in the last 12 months, according to SEC Form 4 filings.
Which superinvestors own Core Laboratories NV?
3 of the superinvestors Investingly tracks hold CLB in their latest 13F, including John Rogers, Will Nasgovitz, Cliff Asness.
Companies like Core Laboratories NV
All Energy stocks · Oil & Gas Equipment & Services stocks · Stock lists
Prices and ratios as of Oct 8, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.